Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

AWH

Aspira Women's Health Inc

May 03 • 04:00PM ET

3.21

Dollar change -0.00
Percentage change -0.10	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-1.78	Insider Own	45.51%	Shs Outstand	10.65M	Perf Week	-3.51%
Market Cap	39.64M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	0.07%	Shs Float	6.73M	Perf Month	18.89%
Income	-16.18M	PEG	-	EPS next Q	-0.33	Inst Own	5.79%	Short Float	2.52%	Perf Quarter	-39.09%
Sales	9.15M	P/S	4.33	EPS this Y	28.41%	Inst Trans	60.31%	Short Ratio	7.51	Perf Half Y	-31.56%
Book/sh	-0.22	P/B	-	EPS next Y	30.48%	ROA	-136.91%	Short Interest	0.17M	Perf Year	-34.38%
Cash/sh	0.21	P/C	15.25	EPS next 5Y	-	ROE	-701.30%	52W Range	2.31 - 6.75	Perf YTD	-21.32%
Dividend Est.	-	P/FCF	-	EPS past 5Y	5.77%	ROI	-	52W High	-52.44%	Beta	1.57
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	25.92%	Gross Margin	57.54%	52W Low	39.04%	ATR (14)	0.26
Dividend Ex-Date	Dec 16, 2016	Current Ratio	1.03	EPS Y/Y TTM	89.53%	Oper. Margin	-200.36%	RSI (14)	42.39	Volatility	8.59% 8.89%
Employees	64	Debt/Eq	-	Sales Y/Y TTM	11.85%	Profit Margin	-176.74%	Recom	2.33	Target Price	5.25
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	97.90%	Payout	-	Rel Volume	1.28	Prev Close	3.21
Sales Surprise	-15.91%	EPS Surprise	32.75%	Sales Q/Q	-1.07%	Earnings	Mar 28 BMO	Avg Volume	22.55K	Price	3.21
SMA20	-2.25%	SMA50	-8.09%	SMA200	-19.53%	Trades		Volume	28,944	Change	-0.10%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-22	Resumed	Cantor Fitzgerald	Overweight	$4
Mar-29-21	Initiated	Truist	Buy	$12
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight	$10
Oct-30-20	Initiated	William Blair	Outperform

May-02-24 08:00AM	Aspira Women's Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch (GlobeNewswire)
Apr-09-24 08:00AM	Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California (GlobeNewswire) +9.93%
Apr-01-24 11:24AM	Aspira Women's Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 11:53AM	AWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -9.62%
07:30AM	Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
08:00AM	Loading…
Mar-25-24 08:00AM	Aspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call (GlobeNewswire)
Mar-21-24 08:00AM	Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference (GlobeNewswire)
Mar-18-24 08:00AM	Aspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President (GlobeNewswire)
Mar-11-24 08:00AM	Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 (GlobeNewswire)
Feb-22-24 08:30AM	Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference (GlobeNewswire) -5.36%
Feb-12-24 08:00AM	Aspira Womens Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) (GlobeNewswire)
Feb-06-24 08:00AM	Aspira Women's Health Announces OvaSuite(SM) Distribution Agreement in the Philippines (GlobeNewswire)
Jan-25-24 08:00AM	Aspira Women's Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Dec-19-23 08:00AM	Aspira Women's Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 (GlobeNewswire)
08:00AM	Loading…
Dec-14-23 08:00AM	Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 (GlobeNewswire)
Dec-08-23 09:46AM	New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT (GlobeNewswire)
Dec-07-23 09:20AM	New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT (GlobeNewswire) +12.84%
Dec-06-23 08:00AM	Aspira Women's Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis (GlobeNewswire)
Nov-28-23 08:00AM	Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal) (GlobeNewswire)
Nov-27-23 09:47AM	Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS) (GlobeNewswire)
Nov-13-23 04:05PM	Aspira Women's Health Reports Third Quarter 2023 Financial Results (GlobeNewswire) -8.82%
Nov-09-23 08:00AM	Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch (GlobeNewswire)
Oct-31-23 08:00AM	Aspira Womens Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023 (GlobeNewswire)
Oct-25-23 08:00AM	Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research (GlobeNewswire) -7.08%
Oct-23-23 08:00AM	Aspira Women's Health Establishes a New Clinical Advisory Board (GlobeNewswire) -8.12%
Oct-20-23 10:43AM	New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT (GlobeNewswire)
Sep-29-23 08:00AM	Aspira Women's Health to Present at the BioVenture Nexus Conference (GlobeNewswire)
Sep-13-23 08:00AM	Aspira Womens Health Regains Nasdaq Compliance (GlobeNewswire) +23.34%
Sep-11-23 08:00AM	Aspira Womens Health Announces Dr. Jody Berry as New Chief Scientific Officer (GlobeNewswire)
08:00AM	Loading…
Aug-31-23 08:00AM	Aspira Womens Health Signs Exclusive Sample Procurement Agreement with The University of Oxford (GlobeNewswire) +14.57%
Aug-29-23 08:00AM	Aspira Womens Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-28-23 08:00AM	Aspira Womens Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations (GlobeNewswire) +6.98%
Aug-14-23 04:01PM	Aspira Womens Health® Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 04:05PM	Aspira Womens Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer (GlobeNewswire)
Jul-31-23 08:00AM	Aspira Womens Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023 (GlobeNewswire)
Jul-20-23 08:30AM	Aspira Womens Health Announces $4.7 Million Registered Direct Offering (GlobeNewswire) -30.90%
Jun-28-23 08:00AM	Aspira Womens Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD (GlobeNewswire) +8.33%
Jun-12-23 06:23PM	New to The Street Announces Five Corporate Interviews on its 478th Show, Airing on the Fox Business Network, Tonight, Monday, June 12, 2023, at 10:30 PM PT (GlobeNewswire)
Jun-08-23 01:23PM	New to The Street TV Announces its Four Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
01:23PM	New to The Street TV Announces its Five Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
Jun-05-23 08:00AM	Aspira Womens Health Appoints Dr. Winfred Parnell to its Board of Directors (GlobeNewswire)
Jun-02-23 09:35AM	New to The Street Announces its Corporate Guests TV Interviews, Airing as Episodes 474 and 475 with Shows Starting on Saturday, June 3, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health Regained Compliance with Nasdaqs Minimum Bid Price Requirement (GlobeNewswire)
May-31-23 08:00AM	Aspira Womens Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment Tests (GlobeNewswire)
May-30-23 08:00AM	Aspira Womens Health to Participate at William Blairs 43rd Annual Growth Stock Conference (GlobeNewswire) -6.00%
May-26-23 09:15AM	New to The Street Announces the Televised Lineups for Shows 471, 472, and 473; Airings on Three Networks Will Begin on Saturday, May 27, 2023, at 3:30 PM ET (GlobeNewswire) -6.42%
May-19-23 09:38AM	New to The Street Announces its Televised Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 469 and 470; Broadcastings Begin Saturday, May 20, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference (GlobeNewswire)
May-16-23 04:05PM	Aspira Womens Health Names Torsten Hombeck as Chief Financial Officer (GlobeNewswire)
May-15-23 04:05PM	Aspira Womens Health to Host Investor Day on OvaWatch(SM) and EndoCheck Market Opportunities on May 23, 2023 (GlobeNewswire) +15.88%
09:00AM	Aspira Womens Health launches its New to The Street Media Series on May 8, 2023, World Ovarian Cancer Day (GlobeNewswire)
May-11-23 04:01PM	Aspira Womens Health® Reports First Quarter 2023 Financial Results (GlobeNewswire) -13.87%
12:33PM	Aspira Womens Health Announces 1-for-15 Reverse Stock Split (GlobeNewswire)
09:45AM	New to The Street Announces the Televised Lineups for Shows 466, 467, and 468; Airings on Three Networks, Starting Thursday, May 11, 2023, at 10:30 PM PT (GlobeNewswire)
08:00AM	Aspira Womens Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test (GlobeNewswire)
May-09-23 04:07PM	Aspira Womens Health Appoints Three New Members to its Board of Directors (GlobeNewswire)
Apr-27-23 04:05PM	Aspira Womens Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023 (GlobeNewswire)
Mar-27-23 07:12AM	Aspira Womens Health Inc. (NASDAQ:AWH) Q4 2022 Earnings Call Transcript (Insider Monkey) -11.70%
Mar-22-23 04:05PM	Aspira Womens Health Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 08:38AM	Aspira Womens Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023 (GlobeNewswire) +19.14%
08:00AM	Aspira Womens Health Announces National Payer Coverage for OvaWatch (GlobeNewswire)
Jan-09-23 04:05PM	Aspira Womens Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights (GlobeNewswire)
Jan-06-23 08:00AM	Aspira Womens Health Announces Publication of Real-World Data Validating Use of OvaWatch for the Management of Adnexal Masses (GlobeNewswire) +14.23%
Dec-27-22 08:00AM	Aspira Womens Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing Portfolio (GlobeNewswire)
Nov-29-22 04:01PM	Aspira Womens Health Announces the Commercial Launch of OvaWatch(SM) (GlobeNewswire)
Nov-10-22 07:00AM	Aspira Womens Health Reports Third Quarter 2022 Financial Results (GlobeNewswire) +6.23%
Nov-01-22 08:00AM	Aspira Womens Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10 (GlobeNewswire)
Oct-06-22 04:05PM	Aspira Womens Health to Participate at the Upcoming MicroCap Rodeo Windy City Roundup 2022 (GlobeNewswire) -11.85%
Oct-05-22 08:00AM	Aspira Womens Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference (GlobeNewswire)
Sep-27-22 09:05AM	60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago (ACCESSWIRE)
Sep-12-22 04:28PM	Aspira Womens Health Announces Publication of its Second-Generation MultiVariate Index Assay, OVERA®, in the Detection of Cancer in Filipino Women (GlobeNewswire)
Aug-23-22 08:00AM	Aspira Womens Health Inc. Announces Pricing of $9.0 Million Public Offering (GlobeNewswire) -37.28%
Aug-22-22 04:02PM	Aspira Womens Health Inc. Announces Proposed Public Offering (GlobeNewswire) -5.92%
Aug-18-22 04:05PM	Aspira Womens Health Hosting Womens Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay (GlobeNewswire)
Aug-10-22 07:30AM	Aspira Womens Health Reports Second Quarter 2022 Financial Results (GlobeNewswire) -9.35%
Aug-01-22 08:00AM	Aspira Womens Health to Announce Second Quarter 2022 Financial Results and Host Conference Call on Wednesday, August 10 (GlobeNewswire)
Jul-11-22 06:26AM	Aspira Women's Health (NASDAQ:AWH) adds US$31m to market cap in the past 7 days, though investors from a year ago are still down 81% (Simply Wall St.) -14.71%
Jun-23-22 04:05PM	Aspira Womens Health Announces Appointment of Two New Board Members (GlobeNewswire) -7.11%
Jun-16-22 04:01PM	Aspira Womens Health Announces Publication of Paper Validating OvaWatch Algorithm in the Detection of Ovarian Cancer (GlobeNewswire) -6.57%
May-18-22 07:31AM	Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet? (Simply Wall St.)
May-16-22 01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE) +28.57%
May-12-22 04:01PM	Aspira Womens Health to Participate in the Upcoming Investor Conferences (GlobeNewswire)
May-11-22 07:30AM	Aspira Womens Health Reports First Quarter 2022 Financial Results (GlobeNewswire) -32.36%
Apr-29-22 08:00AM	Aspira Womens Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11 (GlobeNewswire) -9.41%
Apr-02-22 01:40PM	What Kind Of Shareholders Hold The Majority In Aspira Women's Health Inc.'s (NASDAQ:AWH) Shares? (Simply Wall St.)
Mar-23-22 07:00AM	Aspira Womens Health Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) -9.42%
Mar-15-22 08:00AM	Aspira Womens Health to Announce Year End 2021 Financial Results and Host Conference Call on Wednesday, March 23 (GlobeNewswire)
Feb-28-22 08:14AM	Aspira Womens Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors (GlobeNewswire) -5.22%
Feb-24-22 04:01PM	Valerie Palmieri Elevated to Executive Chair of the Board; Nicole Sandford Appointed President and CEO (GlobeNewswire) +9.00%
Feb-22-22 04:05PM	Aspira Womens Health, Inc. Expands Senior Leadership Team with Addition of Mr. Michael Newton as Head of Sales and Marketing (GlobeNewswire)
Feb-08-22 01:46PM	Aspira Womens Health to Participate in the Upcoming Winter Wonderland Best Ideas Conference (GlobeNewswire)
Feb-01-22 04:19AM	Aspira Women's Health (NASDAQ:AWH) shareholders have endured a 86% loss from investing in the stock a year ago (Simply Wall St.)
Jan-31-22 04:05PM	Aspira Womens Health Announces the Addition of 465,000 Covered Lives Through Medicaid Credentialing (GlobeNewswire) +12.04%
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE)
Jan-05-22 08:00AM	Aspira Womens Health Executes an Agreement with Axia Womens Health to Launch Aspira Synergy Genetics Platform (GlobeNewswire) -6.43%
08:00AM	Aspira Womens Health Appoints Minh Merchant as General Counsel (GlobeNewswire)
08:00AM	Aspira Womens Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs (GlobeNewswire)
Dec-03-21 04:57AM	Is Aspira Women's Health (NASDAQ:AWH) Using Debt In A Risky Way? (Simply Wall St.) -9.95%
Nov-10-21 08:00AM	Aspira Womens Health Reports Third Quarter 2021 Financial Results (GlobeNewswire) -15.64%

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sandford Nicole	President & CEO	Dec 06 '23	Buy	3.36	5,000	16,800	58,703	Dec 06 05:21 PM
Merchant Minh Hoang	Secretary & General Counsel	Dec 06 '23	Sale	3.37	980	3,303	0	Dec 08 05:28 PM
Hombeck Torsten	Chief Financial Officer	Sep 08 '23	Buy	4.30	2,246	9,658	3,000	Sep 12 06:37 PM
SCHULER JACK W	10% Owner	Jul 24 '23	Buy	2.75	181,800	499,950	1,883,656	Jul 25 05:39 PM
Sandford Nicole	President & CEO	Jul 24 '23	Buy	3.98	12,563	50,001	134,665	Jul 25 05:16 PM
Herchuk Jannie Prestridge	Director	Jul 24 '23	Buy	3.98	8,794	35,000	23,833	Jul 24 06:49 PM
Parnell Winfred	Director	Jul 24 '23	Buy	3.98	6,281	24,998	31,513	Jul 25 05:03 PM
Cavanaugh Stefanie L.	Director	Jul 24 '23	Buy	3.98	6,281	24,998	34,904	Jul 25 05:20 PM
Jordan Veronica GH	Director	Jul 24 '23	Buy	3.98	3,769	15,001	34,575	Jul 24 06:58 PM
Vos Ellen O'Connor	Director	Jul 24 '23	Buy	3.98	3,769	15,001	32,878	Jul 26 04:28 PM
Merchant Minh Hoang	General counsel and secretary	Jul 24 '23	Buy	3.98	754	3,001	3,865	Jul 25 04:58 PM
Fralick Celeste Rachelle	Director	Jul 24 '23	Buy	3.98	754	3,001	12,032	Jul 26 07:28 PM
Hombeck Torsten	Chief Financial Officer	Jul 24 '23	Buy	3.98	754	3,001	754	Jul 24 06:53 PM
Phan Ryan Thinh	CSO & COO	Jul 24 '23	Buy	3.98	628	2,499	3,939	Jul 25 05:11 PM

Open in Screener

OPRX

OptimizeRx Corp

May 03 • 04:00PM ET

10.62

Dollar change -0.08
Percentage change -0.75	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO VHT AVUV DFAS IWC AVSC

Index	RUT	P/E	-	EPS (ttm)	-1.02	Insider Own	12.18%	Shs Outstand	18.16M	Perf Week	4.94%
Market Cap	193.07M	Forward P/E	18.52	EPS next Y	0.57	Insider Trans	-0.18%	Shs Float	15.97M	Perf Month	-5.26%
Income	-17.57M	PEG	-	EPS next Q	-0.13	Inst Own	71.87%	Short Float	3.92%	Perf Quarter	-27.66%
Sales	71.52M	P/S	2.70	EPS this Y	44.51%	Inst Trans	-10.24%	Short Ratio	4.68	Perf Half Y	31.11%
Book/sh	6.97	P/B	1.52	EPS next Y	52.60%	ROA	-11.05%	Short Interest	0.63M	Perf Year	-26.51%
Cash/sh	0.76	P/C	13.94	EPS next 5Y	11.50%	ROE	-13.90%	52W Range	6.92 - 16.65	Perf YTD	-25.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.90%	52W High	-36.20%	Beta	1.25
Dividend TTM	-	Quick Ratio	3.04	Sales past 5Y	30.00%	Gross Margin	56.62%	52W Low	53.47%	ATR (14)	0.62
Dividend Ex-Date	-	Current Ratio	3.04	EPS Y/Y TTM	-60.13%	Oper. Margin	-18.49%	RSI (14)	49.46	Volatility	4.54% 5.52%
Employees	136	Debt/Eq	0.29	Sales Y/Y TTM	14.53%	Profit Margin	-24.56%	Recom	1.29	Target Price	16.17
Option/Short	Yes / Yes	LT Debt/Eq	0.27	EPS Q/Q	-1094.24%	Payout	-	Rel Volume	0.77	Prev Close	10.70
Sales Surprise	1.62%	EPS Surprise	-32.22%	Sales Q/Q	44.34%	Earnings	May 14 AMC	Avg Volume	133.86K	Price	10.62
SMA20	4.89%	SMA50	-13.37%	SMA200	-6.15%	Trades		Volume	103,026	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-04-24	Initiated	JMP Securities	Mkt Outperform	$15
Jan-03-24	Initiated	Barclays	Equal Weight	$15
Feb-02-23	Resumed	B. Riley Securities	Buy	$30
Nov-01-22	Initiated	Stifel	Buy	$19
Jul-15-22	Initiated	SVB Leerink	Outperform	$38
Oct-18-21	Resumed	B. Riley Securities	Buy	$102
Apr-13-21	Initiated	RBC Capital Mkts	Outperform	$65
Jan-03-19	Initiated	William Blair	Outperform

Apr-26-24 07:30AM	OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM	After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
Apr-22-24 09:35AM	Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) (Zacks)
Apr-18-24 07:30AM	OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-16-24 07:00AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
07:30AM	Loading…
Apr-11-24 07:30AM	OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row (GlobeNewswire)
Apr-06-24 06:00AM	7 Top Undervalued Stocks Primed for a Multibagger Recovery (InvestorPlace)
Apr-01-24 03:02PM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.01%
Mar-28-24 09:54PM	OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 07:30AM	OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET (GlobeNewswire)
Mar-11-24 04:30PM	OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 (GlobeNewswire)
Mar-04-24 03:51PM	OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort (GlobeNewswire)
Feb-21-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Jan-09-24 07:30AM	OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update (GlobeNewswire) +13.85%
06:19AM	Loading…
Dec-26-23 06:19AM	Should You Exit OptimizeRx Corp. (OPRX)? (Insider Monkey)
Dec-18-23 07:30AM	OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco (GlobeNewswire) +5.98%
Dec-11-23 12:00PM	OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know (Zacks)
Nov-21-23 12:20PM	Why OptimizeRx Corp. (OPRX) Might be Well Poised for a Surge (Zacks)
Nov-20-23 09:55AM	How Much Upside is Left in OptimizeRx Corp. (OPRX)? Wall Street Analysts Think 47.72% (Zacks)
Nov-13-23 11:38AM	OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 02:17AM	Q3 2023 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 08:17AM	OptimizeRx Corp (OPRX) Reports Q3 2023 Earnings, Raises 2023 Guidance and Introduces 2024 Guidance (GuruFocus.com) +15.31%
07:00AM	OptimizeRx Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 10:00AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-25-23 07:30AM	OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET (GlobeNewswire) -5.14%
Oct-13-23 03:59AM	OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains? (Zacks) +5.07%
Oct-12-23 07:00AM	OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers (GlobeNewswire) +13.01%
Sep-26-23 08:00AM	OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform (GlobeNewswire)
08:00AM	Loading…
Aug-24-23 08:00AM	OptimizeRx Expands AI Powered Omnichannel Platform (GlobeNewswire)
Aug-14-23 04:01PM	OptimizeRx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-10-23 06:57AM	Positive Signs As Multiple Insiders Buy OptimizeRx Stock (Simply Wall St.)
Jul-31-23 08:01AM	OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET (GlobeNewswire)
Jun-30-23 10:52AM	OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst institutional investors who own 85% (Simply Wall St.)
Jun-20-23 08:00AM	LifeMD Appoints William J. Febbo to its Board of Directors (GlobeNewswire)
May-24-23 07:30AM	OptimizeRxs CEO Provides 2023 Midyear Strategic Update (GlobeNewswire) +11.70%
May-23-23 07:51PM	Down More Than 50%: These 3 Beaten-Down Stocks Could Stage a Strong Rebound, Analysts Say (TipRanks)
May-18-23 09:00AM	Revenues Tell The Story For OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
08:01AM	OptimizeRxs Karina Castagna Named One of the 2023 PM360 ELITE 100 (GlobeNewswire)
May-15-23 08:00AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-23 05:15PM	OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	OptimizeRx Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 06:38AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 114% gain (Simply Wall St.)
May-02-23 08:00AM	Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance (GlobeNewswire)
Apr-26-23 08:00AM	OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET (GlobeNewswire)
Apr-17-23 10:38AM	Should You Think About Buying OptimizeRx Corporation (NASDAQ:OPRX) Now? (Simply Wall St.)
Apr-04-23 08:01AM	OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Apr-02-23 08:55AM	A Look At The Intrinsic Value Of OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
Mar-29-23 09:20AM	Financial Times Ranks OptimizeRx Amongst The Americas Fastest Growing Companies for the Fourth Consecutive Year (GlobeNewswire)
Mar-15-23 03:18AM	OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock? (Zacks)
Mar-14-23 07:30AM	OptimizeRx Authorizes $15 Million Share Repurchase Program (GlobeNewswire) +7.18%
Mar-12-23 08:40AM	Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Mar-11-23 07:13AM	Analysts Have Lowered Expectations For OptimizeRx Corporation (NASDAQ:OPRX) After Its Latest Results (Simply Wall St.)
Mar-10-23 02:39AM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.78%
Mar-09-23 09:06AM	Q4 2022 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents) -11.64%
08:01AM	OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients (GlobeNewswire)
Mar-08-23 05:25PM	OptimizeRx Corp. (OPRX) Q4 Earnings Beat Estimates (Zacks)
04:01PM	OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 06:56PM	Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
05:02AM	Great news for OptimizeRx Corporation (NASDAQ:OPRX): Insiders acquired stock in large numbers last year (Simply Wall St.)
Mar-02-23 10:54AM	Should You Buy OptimizeRx (OPRX) Ahead of Earnings? (Zacks)
10:00AM	Oracle (ORCL) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-23-23 08:00AM	OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET (GlobeNewswire) +5.15%
Feb-16-23 10:01AM	OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
Feb-09-23 08:30AM	OptimizeRxs Karina Castagna Named to MM+Ms 40 Under 40 List of the Medical Marketing Industrys Brightest Young Stars (GlobeNewswire)
Jan-21-23 09:12AM	With 86% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big guns (Simply Wall St.)
Jan-05-23 06:01AM	Strength Seen in OptimizeRx Corp. (OPRX): Can Its 10.1% Jump Turn into More Strength? (Zacks)
Jan-04-23 07:30AM	OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference (GlobeNewswire) +10.05%
Nov-28-22 09:31AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-14-22 10:44AM	Heres Why Artisan Partners Exited its Position in OptimizeRx Corporation (OPRX) (Insider Monkey)
Nov-10-22 05:58AM	OptimizeRx Third Quarter 2022 Earnings: EPS Beats Expectations (Simply Wall St.) +14.58%
Nov-08-22 05:35PM	OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates (Zacks)
04:01PM	OptimizeRx Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 06:39AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 228% gain (Simply Wall St.)
Oct-24-22 03:53PM	Top 10 Small-Cap Stocks With Highest Upside Potential (Insider Monkey)
Oct-20-22 09:00AM	OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event (GlobeNewswire)
Oct-19-22 04:05PM	OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET (GlobeNewswire)
Oct-11-22 08:00AM	OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution (GlobeNewswire)
Sep-23-22 06:23AM	Is OptimizeRx Corporation (NASDAQ:OPRX) Potentially Undervalued? (Simply Wall St.)
Sep-20-22 08:00AM	OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands (GlobeNewswire)
Sep-07-22 08:00AM	OptimizeRx to Participate in Upcoming September Conferences (GlobeNewswire)
Aug-23-22 09:18AM	OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program (GlobeNewswire)
Aug-19-22 06:19AM	Chief Commercial Officer Stephen Silvestro Just Bought A Handful Of Shares In OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
Aug-10-22 09:22AM	Macro Factors Behind OptimizeRx's Weaker Than Expected Q2 Earnings, Lowers Annual Guidance (Benzinga) -30.02%
12:31AM	OptimizeRx Corporation (OPRX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 08:16PM	UPDATE OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense (GlobeNewswire) -6.43%
06:35PM	OptimizeRx Corp. (OPRX) Misses Q2 Earnings and Revenue Estimates (Zacks)
04:05PM	OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense (GlobeNewswire)
Aug-02-22 10:00AM	OptimizeRx Corp. (OPRX) Reports Next Week: What to Know Ahead of the Release (Zacks)
Jul-26-22 07:30AM	OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership (GlobeNewswire) +8.16%
Jul-25-22 10:13AM	Down More Than 50%: These 2 Strong Buy Stocks Are Trading at Rock-Bottom Prices (TipRanks)
Jul-21-22 07:30AM	OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET (GlobeNewswire)
Jul-15-22 03:10PM	SVB Leerink Sees 'Cheaper Way' To Pharma Digital Marketing With This Stock (Benzinga) +5.08%
Jun-27-22 10:52AM	OptimizeRx Corp. (OPRX) Moves 8.9% Higher: Will This Strength Last? (Zacks)
Jun-23-22 07:30AM	OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership (GlobeNewswire)
Jun-16-22 12:27PM	5 Small-Cap Stocks That Are Diamonds in the Rough (InvestorPlace)
Jun-07-22 08:00AM	OptimizeRx Completes Platform Integration of TelaRep One-Click Prescriber Connectivity Solution (GlobeNewswire)
May-24-22 08:00AM	OptimizeRx to Participate in Upcoming June Conferences (GlobeNewswire)
May-17-22 10:00AM	OptimizeRxs Mike Rousselle Named One of 2022 PM360 ELITE 100 (GlobeNewswire) +12.30%

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Silvestro Stephen L	Chief Commercial Officer	Mar 01 '24	Option Exercise	0.00	1,927	0	6,624	Mar 06 04:20 PM
Odence-Ford Marion	General Counsel and CCO	Mar 01 '24	Option Exercise	0.00	771	0	14,499	Mar 06 04:19 PM
Odence-Ford Marion	General Counsel and CCO	Feb 11 '24	Option Exercise	0.00	4,000	0	15,114	Feb 13 06:16 PM
FEBBO WILLIAM J	CEO	Jan 09 '24	Option Exercise	0.00	9,628	0	481,028	Jan 18 05:56 PM
Odence-Ford Marion	General Counsel and CCO	Jan 09 '24	Sale	15.19	4,000	60,751	11,114	Jan 11 05:06 PM
Odence-Ford Marion	General Counsel and CCO	Nov 08 '23	Option Exercise	0.00	1,785	0	15,638	Nov 13 02:32 PM
Stelmakh Edward	CFO/COO	Oct 11 '23	Option Exercise	0.00	6,155	0	31,603	Oct 12 02:18 PM
Silvestro Stephen L	Chief Commercial Officer	Oct 03 '23	Option Exercise	0.00	6,649	0	6,649	Oct 06 02:47 PM
Odence-Ford Marion	General Counsel and CCO	Oct 03 '23	Option Exercise	0.00	6,649	0	15,805	Oct 06 02:47 PM
Besch Doug	Chief Product Officer	Oct 03 '23	Option Exercise	0.00	3,324	0	4,824	Oct 06 02:47 PM
Stelmakh Edward	CFO/COO	Oct 03 '23	Option Exercise	0.00	16,662	0	21,344	Oct 06 02:47 PM
HALAS GUS D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	70,865	Aug 18 10:03 AM
Spangler Patrick D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	22,120	Aug 18 09:33 AM
Lang James Paul	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	44,697	Aug 18 09:31 AM
Vos Ellen O'Connor	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	39,427	Aug 18 09:29 AM
WASSON GREGORY D	Director	Jun 07 '23	Option Exercise	0.00	4,637	0	23,968	Aug 18 09:28 AM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

AWH

Aspira Women's Health Inc

OPRX

OptimizeRx Corp

Upgrade your FINVIZ experience